Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People's Republic of China. The company offers surgical aesthetic treatments, such as eye lid surgery, rhinoplasty, breast augmentation, liposuction, facelifts; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services. The company was founded in 1997 and is headquartered in Shenzhen, the People's Republic of China.
Frequently asked questions
What sector does AEST.MED.INT.HLD.SP.ADR/3 (3FMA) operate in?
AEST.MED.INT.HLD.SP.ADR/3 belongs to the Healthcare sector and operates in the Medical Care Facilities industry.
What is AEST.MED.INT.HLD.SP.ADR/3 (3FMA) current stock price?
As of the latest data, AEST.MED.INT.HLD.SP.ADR/3 stock price is €0.01, with a previous close of €0.01.
What is AEST.MED.INT.HLD.SP.ADR/3 (3FMA) current market capitalization?
AEST.MED.INT.HLD.SP.ADR/3 market cap is approximately 438.19 thousand.
What is AEST.MED.INT.HLD.SP.ADR/3 (3FMA) Earnings Per Share (EPS)?
The trailing EPS is -€0.15.
Does AEST.MED.INT.HLD.SP.ADR/3 (3FMA) pay dividends?
No. AEST.MED.INT.HLD.SP.ADR/3 does not pay a dividend.
What is AEST.MED.INT.HLD.SP.ADR/3 (3FMA) beta (volatility) score?
AEST.MED.INT.HLD.SP.ADR/3 has a beta of -0.677, indicating lower volatility than the overall market.
